ctDNA Identifies Colon Cancer Patients Who Can Skip Chemo - Medscape
6/4/2022 12:00:00 AM2 years 10 months ago
by Sharon Worcester, MA
by Sharon Worcester, MA
A liquid biopsy to detect circulating tumor DNA after surgery for stage 2 colon cancer reduces the use of chemotherapy without sacrificing recurrence-free survival.
A "liquid biopsy" that detects circulating tumor DNA (ctDNA) after surgery for stage 2 colon cancer helps identify patients who are most likely to benefit from adjuvant chemotherapy, and also identif… [+6048 chars]
full article...